Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2‐negative breast cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|17|2657-2664

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.17, 2014-09, pp. : 2657-2664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapy of HER2-Negative Breast Cancer

Oncology Research and Treatment, Vol. 39, Iss. 3, 2016-02 ,pp. : 118-121

Karger

Access to resources Recommend Favorite

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J. Ricci Jr. Andrew

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

HER2/neu vaccines in breast cancer

By Khoo Steven Ponniah Sathibalan Peoples George E

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 217-223

Future Medicine

Access to resources Recommend Favorite

The Predictive Value of HER2 in Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

HER2 as a Prognostic Factor in Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 67-72

Karger

Access to resources Recommend Favorite